Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway
- 31 March 2009
- journal article
- clinical trial
- Published by Elsevier BV in Clinical Immunology
- Vol. 130 (3), 244-251
- https://doi.org/10.1016/j.clim.2008.10.007
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Inhibition of Urinary Bladder Carcinogenesis by Broccoli SproutsCancer Research, 2008
- Importance of oxidative stress in the pathogenesis and treatment of asthmaCurrent Opinion in Allergy and Clinical Immunology, 2008
- Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiationProceedings of the National Academy of Sciences of the United States of America, 2007
- Gene-Air Pollution Interactions in AsthmaProceedings of the American Thoracic Society, 2007
- Antioxidant Enzyme Induction: A New Protective Approach Against the Adverse Effects of Diesel Exhaust ParticlesInhalation Toxicology, 2007
- GlutathioneS-Transferases M1 and P1 Prevent Aggravation of Allergic Responses by Secondhand SmokeAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Biology of diesel exhaust effects on respiratory functionJournal of Allergy and Clinical Immunology, 2005
- Effect of Topical Fluticasone Propionate on the Mucosal Allergic Response Induced by Ragweed Allergen and Diesel Exhaust Particle ChallengeClinical Immunology, 1999
- Allergen-irritant interaction and the role of corticosteroidsAllergy, 1997
- Diesel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms.JCI Insight, 1994